38 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Spero Therapeutics Competitors or Alternatives

Spero Therapeutics's top competitors include Melinta, Tetraphase and Cipla.

Unlock 5 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Spero Therapeutics's company profile

Sath Shukla

President & CEO

82/100
150
$463.8M
$48M
  • $463.8M
    $48M
  • 150
    $463.8M
  • $48M
  • 82/100
  • 150
  • $463.8M
  • $48M
View ProfileView
1
Spero Therapeutics's Competitor - Melinta logo

Christine Ann Miller

President & CEO

88/100
250 - 500
$558.3M
$25M - 100M
  • $558.3M
    $25M - 100M
  • 250 - 500
    $558.3M
  • $25M - 100M
  • 88/100
  • 250 - 500
  • $558.3M
  • $25M - 100M
View ProfileView
2
Spero Therapeutics's Competitor - Tetraphase logo

Larry Edwards

CEO

93/100
25 - 100
$172M
$5M - 25M
  • $172M
    $5M - 25M
  • 25 - 100
    $172M
  • $5M - 25M
  • 93/100
  • 25 - 100
  • $172M
  • $5M - 25M
View ProfileView
3
Spero Therapeutics's Competitor - Cipla logo

Umang Vohra

Managing Director & CEO

57/100
40,993
- -
$3.2B
  • - -
    $3.2B
  • 40,993
    - -
  • $3.2B
  • 57/100
  • 40,993
  • - -
  • $3.2B
View ProfileView
4
Spero Therapeutics's Competitor - Adenium Biotech logo

Paul Goldenheim

CEO

73/100
1 - 25
- -
$5M - 25M
  • - -
    $5M - 25M
  • 1 - 25
    - -
  • $5M - 25M
  • 73/100
  • 1 - 25
  • - -
  • $5M - 25M
View ProfileView
5
Spero Therapeutics's Competitor - Achaogen logo

Blake Wise

CEO

77/100
1 - 25
$221.4M
$100K - 5M
  • $221.4M
    $100K - 5M
  • 1 - 25
    $221.4M
  • $100K - 5M
  • 77/100
  • 1 - 25
  • $221.4M
  • $100K - 5M
View ProfileView
Spero Therapeutics' top 8 competitors are Melinta, Tetraphase, Cipla, UTILITY Therapeutics, Adenium Biotech, Achaogen, VIBATIV and Pear. Together they have raised over 1.4B between their estimated 41.4K employees. Spero Therapeutics has 150 employees and is ranked 3rd among it's top 10 competitors. The top 10 competitors average 5,195.

Spero Therapeutics VS Melinta

Melinta is seen as one of Spero Therapeutics's biggest rivals. Melinta was founded in 2000 in Morristown, New Jersey. Like Spero Therapeutics, Melinta also operates in the Biotechnology sector. Melinta generates $49M more revenue than Spero Therapeutics.

Spero Therapeutics VS Tetraphase

Tetraphase is one of Spero Therapeutics's top competitors. Tetraphase was founded in 2006, and its headquarters is in Waltham, Massachusetts. Like Spero Therapeutics, Tetraphase also operates in the Pharmaceuticals space. Tetraphase has 84 fewer employees than Spero Therapeutics.

Spero Therapeutics VS Cipla

Cipla is one of Spero Therapeutics's top rivals. Cipla was founded in 1935, and is headquartered in Mumbai, Maharashtra. Like Spero Therapeutics, Cipla also works within the Pharmaceuticals sector. Cipla generates $3.2B more revenue vs. Spero Therapeutics.

Looking for similar companies to Spero Therapeutics?

Similar Companies

Pharmaceuticals companies in Cambridge

See 183 companies 
Biotechnology companies in Cambridge

See 561 companies 
Pharmaceuticals companies in Massachusetts

See 516 companies 
Pharmaceuticals companies in Greater Boston

See 500 companies 
Pharmaceuticals & Biotechnology companies in Cambridge

See 698 companies 
Pharmaceuticals companies with revenue in $25-100M range

See 828 companies 
Companies in Cambridge with revenue in $25-100M range

See 854 companies 
Biotechnology companies with revenue in $25-100M range

See 862 companies 
Biotechnology companies in Greater Boston

See 1,266 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Spero Therapeutics and Spero Therapeutics's Competitors

April 29, 2025Citybizlist
CAMBRIDGE, Mass., April 28, 2025 (GLOBE NEWSWIRE) - Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company, focused on ide...
April 29, 2025Marketscreener
CAMBRIDGE , Britain (AP) - CAMBRIDGE , Britain (AP) - Astrazeneca PLC (AZN) on Tuesday reported first-quarter profit of $2.92 billion . On a per-share ...
April 28, 2025The Korea Bizwire
MILAN, April 28, 2025 (Korea Bizwire) - Olon Group, a leading global pharmaceutical CDMO, announces the appointment of Jérôme Bédier as CEO of its Fren...

Frequently Asked Questions about Spero Therapeutics

  1. Who are Spero Therapeutics's top competitors?

    Spero Therapeutics's top 3 competitors are Melinta, Tetraphase, Cipla.

  2. Who is similar to Spero Therapeutics?

    Melinta is the most similar to Spero Therapeutics. Tetraphase and Cipla are also similar to Spero Therapeutics.

  1. Are Spero Therapeutics and Melinta competitors?

    Yes, Melinta is one of Spero Therapeutics’s top competitors.